Continuous Passive Motion (CPM) remains covered by statutory health insurance in Germany

15

Aug 2019

Domestic use of motor-driven moving splints (continuous passive motion, CPM) after interventions at the knee or shoulder joint remains covered by statutory health insurance. This has been determined by the G-BA (the Federal Joint Committee).

Motor-driven motion rails are used for passive movement of the knee and shoulder joint after its injury or damage. The described devices are presented in the list of aids of the GKV-Spitzenverband under the number 32 "Therapeutic exercise devices."

The use of the CPM can be carried out within the scope of conservative treatment as well as after surgical interventions. The prerequisite is the presence of a significant functional impairment of a knee or shoulder joint, in which a distinctive improvement in the daily range of motion - despite regular physical therapy measures - can only be achieved by the additional application of a CPM. The application must be integrated into a corresponding treatment concept.

According to the law, the G-BA can examine whether certain contractual medical services should still be financed at the expense of the statutory health insurance (SHI). At the request of the GKV-Spitzenverband, the G-BA had now carried out such an examination for the use of CPM after interventions on knee and shoulder joints. As a result, the G-BA decided on June 20, 2019, that CPM after interventions on the knee and shoulder joint will remain covered by SHI. The CPM splints are correspondingly included in Annex I "Recognized examination or treatment methods" of the Directive on Contract Medical Care.

The Federal Ministry of Health is now examining the decision of the G-BA (in term of up to two months). In case of no objection, the resolution will come into effect the next day after publication in the Federal Gazette.

The full details in German can be found here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

09

Mar 2022

On February 16, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) has published the decisions which recommended the transfer to standard care for three completed projects. The projects relate to the prevention of antibiotic resistance, improvement of healthcare in socially disadvantaged areas, and misuse of control colonoscopies in Germany.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more